AppLovin vs. Snap: Which Technology Stock Is a Better Buy in 2026?

AppLovin and Snap are compared as advertising-focused technology stocks for 2026. AppLovin demonstrates exceptional growth with 70% revenue increase, 60.8% net margins, and $3.9B free cash flow, while Snap serves 971M users but remains unprofitable with -7.8% net margins despite improving losses. The article recommends AppLovin due to its superior profitability and growth trajectory versus Snap's ongoing path to consistent profitability.

10/21/2026, 8:13 AM • The Motley Fool

INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - HIMS

Robbins Geller announces a class action lawsuit against Hims & Hers Health, Inc. for allegedly sharing consumers' health information with third-party advertising platforms and charging for prescriptions immediately after intake forms despite claiming personalized consultations. The FTC filed a lawsuit on July 29, 2026, leading to a 15% decline in Hims & Hers stock. Investors with substantial losses can seek lead plaintiff status before November 2, 2026.

10/15/2026, 7:00 AM • GlobeNewswire

Robbins LLP Reminds HIMS Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action

Robbins LLP is reminding investors of a pending class action lawsuit against Hims & Hers Health, Inc. for allegedly sharing consumers' sensitive health information with advertising platforms while claiming privacy protection, and engaging in deceptive billing practices. The FTC filed a lawsuit on July 29, 2026, which caused HIMS stock to decline 14.73%. Investors who purchased securities between August 4, 2025 and July 29, 2026 may be eligible to participate, with a lead plaintiff deadline of November 2, 2026.

10/14/2026, 7:53 PM • GlobeNewswire

Hims & Hers Health (NYSE: HIMS) Faces Securities Fraud Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower - HBSS

Hims & Hers Health (NYSE: HIMS) faces a securities class action lawsuit following an FTC complaint alleging the company deceptively shared consumers' health data with third-party advertising platforms like Meta and Snap, and violated billing regulations by charging for prescriptions before medical consultations. The stock plunged 14.7% on July 29, 2026, erasing over $970 million in market value.

10/09/2026, 6:12 PM • GlobeNewswire

1 MONTH INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit before November 2, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - HIMS

Robbins Geller Rudman & Dowd LLP announced a class action lawsuit against Hims & Hers Health, Inc. following FTC allegations that the telehealth provider shared consumers' sensitive health information with third-party advertising platforms including Meta and Snap, and engaged in deceptive billing practices. The lawsuit covers securities purchased between August 4, 2025 and July 29, 2026, with a lead plaintiff deadline of November 2, 2026. Hims & Hers shares declined nearly 15% following the FTC announcement.

10/02/2026, 6:50 AM • GlobeNewswire

Hims & Hers Health (HIMS) Investors with Substantial Losses Have Opportunity to Lead Hims & Hers Class Action Lawsuit—HBSS

Hims & Hers Health (HIMS) faces a securities class action lawsuit following an FTC complaint alleging the company shared consumers' health data with third-party advertisers like Meta and Snap, charged for prescriptions before medical consultations, and violated ROSCA regulations. The stock dropped 14.7% on July 29, 2026, erasing over $970 million in market value. Investors with substantial losses are encouraged to participate in the class action.

09/30/2026, 10:59 AM • GlobeNewswire

Upcoming Blaze Wilde Podcast on Snapchat Exploring Pop Culture, Politics, and Life Between Arab and American Culture

cauZmik Inc is launching a new Snapchat podcast in partnership with Los Angeles-based model and creator Blaze Wilde in October 2026. The podcast will feature candid conversations about pop culture, politics, Arab identity, and Wilde's experiences living between the UAE and the United States, drawing from his modeling career and social media presence.

09/26/2026, 12:24 PM • GlobeNewswire

HIMS Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages HIMS Investors with Losses to Contact the Firm

A securities fraud class action lawsuit has been filed against Hims & Hers Health, Inc. for allegedly making materially false statements about its privacy practices. The FTC accused HIMS of sharing customers' medical information with third-party advertisers including Meta and Snap, and charging consumers for prescriptions without proper consultation. The stock declined 14.73% on the news, dropping $4.32 per share to $25.00 on July 29, 2026.

09/25/2026, 4:51 PM • GlobeNewswire

AppLovin vs. Reddit: Which Technology Stock Is a Better Buy in 2026?

The article compares AppLovin and Reddit as digital advertising investment opportunities. AppLovin boasts higher profitability with 60.8% net margins and $5.5B in FY2025 revenue, but faces legal challenges and competitive pressures. Reddit shows strong growth with 69.4% YoY revenue increase, newly achieved profitability, and a unique AI data licensing business. The author recommends Reddit for its durable growth foundation, unique data assets, and consistent user engagement, despite AppLovin's superior margins.

09/24/2026, 2:26 PM • The Motley Fool

Snap Has Launched Its High-Powered Glasses. Will There Be Enough Demand?

Snap launched its Specs augmented reality glasses on September 16 at $2,195 per pair. Despite partnerships with major tech companies, investor concerns about demand and profitability persist. The AR glasses market remains niche with only 950,000 units forecasted to ship this year, while Meta dominates with 7 million smart glasses sold in 2025. Snap's stock has fallen 90% over five years, making Specs a critical turnaround effort for the struggling social media company.

09/23/2026, 5:32 AM • The Motley Fool

INVESTOR ALERT: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - HIMS

A class action lawsuit has been filed against Hims & Hers Health, Inc. alleging the telehealth company made false statements about consumer privacy and billing practices. The FTC filed a lawsuit on July 29, 2026, claiming Hims & Hers shared sensitive health information with third-party advertising platforms like Meta and Snap, and charged consumers for prescriptions immediately after intake forms despite promising consultation with medical providers. The stock declined nearly 15% following the FTC announcement. Investors with substantial losses can seek lead plaintiff status before November 2, 2026.

09/13/2026, 4:40 PM • GlobeNewswire

Stock Market Today, Sept. 9: Meta Surges Over 6.5% on Muse AI Agent Launch

Meta Platforms surged 6.55% to $653.69 on September 9, 2026, following the launch of Muse, its new personal AI agent capable of shopping, booking flights, and organizing calendars. The autonomous product could unlock new revenue streams and validate Meta's substantial AI investments. Morgan Stanley estimates the AI agent market could be worth around $30 trillion. However, analysts recommend waiting for concrete adoption and revenue data before reassessing the stock.

09/09/2026, 5:15 PM • The Motley Fool

Hims & Hers Health (NYSE: HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS

Hims & Hers Health (NYSE: HIMS) faces a securities class action lawsuit following an FTC complaint alleging the company engaged in deceptive health data sharing with advertising platforms like Meta and Snap, and violated billing regulations by charging consumers for prescriptions before medical consultations. The lawsuit, filed by the FTC alongside Utah and Los Angeles County, also accuses Hims of using dark patterns to prevent subscription cancellations. The stock dropped 14.7% ($4.32) on July 29, 2026, erasing over $970 million in market value.

09/02/2026, 5:34 PM • GlobeNewswire

Snapchat Is Still Losing Money 15 Years Later Despite 971 Million Monthly Average Users

Snapchat remains unprofitable after 15 years despite having 971 million monthly active users and 19% year-over-year revenue growth. While the company projects positive net income in 2027, concerning trends show declining daily active users in North America and Europe—its most profitable markets—with growth only coming from lower-ARPU international regions. Meta Platforms continues to outpace Snapchat's growth rate at 28% YoY.

08/31/2026, 12:15 PM • The Motley Fool

Snap's CFO Sells Nearly 132,000 Shares. Here's What That Means for Investors.

Snap Inc.'s CFO Douglas Hott sold approximately 132,000 shares (~$685,797) on August 17, 2026, as a non-discretionary transaction to fulfill tax withholding obligations from RSU vesting. Hott retained 2.3 million shares post-transaction. The sale comes amid a challenging period for Snap, with the stock down 28% over the past year and recent legal concerns regarding Section 230 immunity for social media platforms.

08/20/2026, 1:14 AM • The Motley Fool